China Substance Abuse Treatment Market Overview
As per MRFR analysis, the China Substance Abuse Treatment Market Size was estimated at 486 (USD Million) in 2023.The China Substance Abuse Treatment Market Industry is expected to grow from 546(USD Million) in 2024 to 1,860 (USD Million) by 2035. The China Substance Abuse Treatment Market CAGR (growth rate) is expected to be around 11.787% during the forecast period (2025 - 2035).
Key China Substance Abuse Treatment Market Trends Highlighted
Rising awareness and changing views about drug misuse are driving many significant developments in the China Substance Abuse Treatment Market. Rising drug addiction among young people, especially in relation to synthetic narcotics and opioids, has led the Chinese government to adopt many measures meant to fight substance misuse. Rising initiatives, including improved public health campaigns and educational programs, are helping to propel demand for more thorough treatment choices. The government's emphasis on enhancing mental health services has also opened the door for integrated treatment strategies combining mental health support with drug misuse care, so serving a more general spectrum of requirements for those looking for assistance.
Especially in the area of technological integration, possibilities in this sector are ripe for the grabbing. Especially in remote locations where access to conventional treatment centres may be restricted, the growth of telemedicine and Internet counselling services provides a fresh path for addressing drug dependence. Furthermore, more people are choosing holistic and individualized treatment programs that go beyond traditional approaches, suggesting a market shift towards alternative treatments and support groups. Lately, cooperation between government organizations and private hospitals to improve the general efficacy of treatment programs has been very obvious.
Community-based projects are also becoming more popular since they emphasize rehabilitation and reintegration of recovered addicts into society. These initiatives underline a movement towards a more inclusive attitude towards drug misuse, seeking to reduce stigma and foster acceptance. For those wanting to grasp the dynamics of the China Substance Abuse Treatment Market, these trends and changes are especially important as the market evolves.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
China Substance Abuse Treatment Market Drivers
Increasing Substance Abuse Cases in China
The prevalence of substance abuse in China has risen dramatically in recent years, especially with the increase in the consumption of opioids and synthetic drugs. According to the National Narcotics Control Commission of China, the number of registered drug users in China reached over 2.5 million in 2020, marking a substantial increase compared to previous years. This alarming trend drives the demand for effective substance abuse treatment solutions.
With governmental entities like the Narcotics Control Bureau increasing funding for rehabilitation programs, there is a significant market opportunity emerging in the China Substance Abuse Treatment Market Industry. By focusing on policies aimed at reducing drug-related crimes and increasing availability of treatment, authorities are contributing to a market poised for growth, reflecting a holistic approach towards tackling addiction within the community.
Government Initiatives and Support Programs
The Chinese government has implemented various initiatives to combat substance abuse, such as the '13th Five-Year Plan' which emphasizes the importance of drug rehabilitation and prevention. Such policies not only provide funding for treatment facilities but also raise awareness about the dangers of drug abuse.Â
The establishment of specialized treatment centers backed by organizations such as the Ministry of Health serves to create a solid foundation for growth in the China Substance Abuse Treatment Market Industry.Moreover, local governments are encouraged to integrate substance abuse treatment into public health initiatives, which systematically supports the increasing demand for comprehensive treatment services.
Rising Mental Health Awareness
As mental health awareness grows in China, the stigma associated with substance abuse is gradually diminishing. According to findings from the China Health and Nutrition Survey, roughly 16% of the population showed signs of mental disorders, which correlates with substance abuse cases. This growing acknowledgment of mental health issues encourages individuals to seek treatment, thereby expanding the market for substance abuse treatment facilities and services.
Organizations such as the Chinese Mental Health Association are actively promoting public awareness campaigns, leading to a significant increase in the number of people seeking assistance for substance use disorders. This change in societal perception is vital for the expansion of the China Substance Abuse Treatment Market Industry.
China Substance Abuse Treatment Market Segment Insights
Substance Abuse Treatment Market Type Insights
The China Substance Abuse Treatment Market is experiencing significant developments, driven by rising awareness and increasing cases of substance dependence among the population. Within this market, the Type segment encompasses various areas of treatment including Alcohol Dependence, Tobacco, and Drug Abuse. Alcohol Dependence is particularly significant as it poses severe health risks and societal implications, prompting a series of treatment programs aimed at reducing consumption and promoting recovery. Tobacco usage in China remains a critical concern, triggering comprehensive public health initiatives focused on cessation strategies and support systems for individuals striving to quit.
Furthermore, Drug Abuse encompasses a variety of illicit substances, leading to tailored treatment solutions that address both physical and psychological dependencies. The growing rate of drug-related issues has accentuated the need for dedicated therapeutic measures, making this segment pivotal in shaping effective intervention strategies. Addressing these issues requires a multifaceted approach, incorporating behavioral therapies, medications, and community support to foster long-lasting recovery outcomes for individuals in China.Â
As the government continues to prioritize substance abuse treatment through policy reforms and increased funding, the market is set for continued growth and evolution, providing vital resources for those affected by substance use disorders.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Substance Abuse Treatment Market End User Insights
The End User segment of the China Substance Abuse Treatment Market encompasses various facilities that play a critical role in addressing substance addiction, including Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers. Outpatient Treatment Centers offer flexibility, allowing patients to maintain their daily commitments while receiving support, which is vital in urbanized areas of China where commuting is common. On the other hand, Residential Treatment Centers provide a more immersive experience, usually preferred for severe cases, as they facilitate around-the-clock supervision and access to therapeutic programs.Inpatient TreatmentÂ
Centers are crucial for patients requiring medical detoxification and urgent intervention, helping to stabilize their condition in a controlled environment. As the prevalence of substance abuse continues to grow in China, these facilities are becoming increasingly significant in the overall treatment landscape. Moreover, China's government initiatives aimed at combating substance addiction have further spurred the development of these centers, reflecting a societal recognition of the importance of specialized treatment options.The market dynamics suggest that these centers are not only vital in treating addiction but also in providing preventative measures to curb the rising trend of substance abuse.
China Substance Abuse Treatment Market Key Players and Competitive Insights
The China Substance Abuse Treatment Market is experiencing a notable evolution driven by increasing awareness of substance abuse issues and the growing burden of addiction on public health. As the market expands, competition intensifies among various players, including pharmaceutical companies, rehabilitation centers, and healthcare providers. The rising prevalence of substance abuse disorders in China necessitates innovative treatment options and holistic care approaches. The competitive landscape is further influenced by regulatory policies, the integration of technology in treatment solutions, and partnerships between public and private sectors aimed at improving treatment accessibility and efficacy. As a result, market participants are compelled to enhance their offerings, address patient needs, and differentiate themselves in a rapidly changing environment.
Qingdao Huanghai Pharmaceutical has established itself as a significant player in the China Substance Abuse Treatment Market through its commitment to developing high-quality pharmaceutical products. The company leverages its strong R&D capabilities to innovate and provide effective treatment options for substance abuse disorders. With a robust distribution network across China, Qingdao Huanghai Pharmaceutical ensures that its products reach a broad customer base, facilitating timely intervention and care for individuals struggling with addiction. The company’s well-established presence in the market is bolstered by strategic collaborations and partnerships, enhancing its ability to adapt to evolving consumer demands and regulatory requirements, positioning itself favorably within the competitive landscape.
Shanghai Mental Health Center plays a vital role in the China Substance Abuse Treatment Market by offering comprehensive mental health services, including specialized treatments for substance abuse. This institution is recognized for its evidence-based approaches and cutting-edge therapeutic practices, providing a range of services such as counseling, rehabilitation programs, and educational resources. By fostering partnerships with various healthcare providers and institutions, Shanghai Mental Health Center enhances its market presence, ensuring a collaborative approach to addiction treatment.Â
The center's emphasis on research and innovation enables it to remain at the forefront of mental health and substance abuse treatment in China. Additionally, ongoing investments in training and development for healthcare professionals further strengthen its service quality, making it a reputable choice for individuals seeking support in managing substance abuse issues.
Key Companies in the China Substance Abuse Treatment Market Include:
- Qingdao Huanghai Pharmaceutical
- Shanghai Mental Health Center
- Shenzhen Hanhai Pharmaceutical
- Zhejiang Huadong Medicine
- Nanjing Baiyu Pharmaceutical
- Jiangsu Chiatai Qingjian Pharmaceutical
- Hunan Yanshan Pharmaceutical
- Guangdong Saiqi Pharmaceutical
- Shenzhen Xisen Pharmaceutical
- Tianjin Jinxi Pharmaceutical
- Shanghai Zhangjiang Pharmaceutical
- Sichuan New Huadu Pharmaceutical
- Xi'an Yufeng Pharmaceutical
- Beijing Tiantan Hospital
- Zhongshan Zhenye Pharmaceutical
China Substance Abuse Treatment Market Industry Developments
The China Substance Abuse Treatment Market has witnessed significant developments recently, marked by an increasing focus on innovative treatment methods and growing governmental support for addiction recovery initiatives. Companies such as Qingdao Huanghai Pharmaceutical, Shanghai Mental Health Center, and Shenzhen Hanhai Pharmaceutical are making strides in Research and Development efforts to enhance therapeutic options.Â
Current affairs in the market reveal ongoing initiatives aimed at expanding facilities and improving accessibility to treatment programs, addressing the rising cases of substance abuse in urban areas. Notably, in March 2023, Zhejiang Huadong Medicine announced a strategic partnership with local health authorities to advance outreach programs that offer mental health support alongside substance abuse treatment. Meanwhile, in July 2022, Jiangsu Chiatai Qingjian Pharmaceutical acquired a minority stake in a new rehabilitation center in Hunan province, further enhancing its service offerings.Â
The market has seen substantial growth, driven by increasing awareness of mental health issues and the urgent need for effective intervention strategies. Such developments contribute to shaping a more robust framework for combating substance addiction across China, while companies like Guangdong Saiqi Pharmaceutical and Tianjin Jinxi Pharmaceutical are increasing their market presence through innovative products and services tailored to address specific community needs.
China Substance Abuse Treatment Market Segmentation Insights
Substance Abuse Treatment Market Type Outlook
- Alcohol Dependence
- Tobacco & Drug Abuse
Substance Abuse Treatment Market End User Outlook
- Outpatient Treatment Centers
- Residential Treatment Centers
- Inpatient Treatment Centers
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
486.0(USD Million) |
MARKET SIZE 2024 |
546.0(USD Million) |
MARKET SIZE 2035 |
1860.0(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
11.787% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Million |
KEY COMPANIES PROFILED |
Qingdao Huanghai Pharmaceutical, Shanghai Mental Health Center, Shenzhen Hanhai Pharmaceutical, Zhejiang Huadong Medicine, Nanjing Baiyu Pharmaceutical, Jiangsu Chiatai Qingjian Pharmaceutical, Hunan Yanshan Pharmaceutical, Guangdong Saiqi Pharmaceutical, Shenzhen Xisen Pharmaceutical, Tianjin Jinxi Pharmaceutical, Shanghai Zhangjiang Pharmaceutical, Sichuan New Huadu Pharmaceutical, Xi'an Yufeng Pharmaceutical, Beijing Tiantan Hospital, Zhongshan Zhenye Pharmaceutical |
SEGMENTS COVERED |
Type, End User |
KEY MARKET OPPORTUNITIES |
Telehealth services expansion, Tailored treatment programs, Increased public awareness campaigns, Integration of mental health support, Government funding initiatives |
KEY MARKET DYNAMICS |
increasing prevalence of substance abuse, government regulation and funding, emerging telehealth treatment options, growing public awareness campaigns, stigma reduction initiatives |
COUNTRIES COVERED |
China |
Frequently Asked Questions (FAQ) :
The China Substance Abuse Treatment Market is expected to be valued at 546.0 million USD in 2024.
By 2035, the China Substance Abuse Treatment Market is projected to reach a value of 1860.0 million USD.
The market is expected to witness a compound annual growth rate of 11.787% over the forecast period from 2025 to 2035.
The Alcohol Dependence segment is valued at 250.0 million USD in 2024, indicating a significant share of the market.
The Tobacco & Drug Abuse segment is projected to reach a value of 1000.0 million USD by the year 2035.
Key players include Qingdao Huanghai Pharmaceutical, Shanghai Mental Health Center, and Shenzhen Hanhai Pharmaceutical among others.
The market offers growth opportunities due to the rising prevalence of substance abuse disorders and increased awareness regarding treatment options.
While both segments are growing, the Alcohol Dependence segment is valued lower than the Tobacco & Drug Abuse segment in 2024 but is projected to catch up by 2035.
Challenges include regulatory hurdles and the stigma associated with seeking treatment for substance abuse in Chinese society.
Emerging trends such as telehealth and personalized treatment approaches are expected to positively impact the growth of the China Substance Abuse Treatment Market.